1-4 of 4
Christopher Goebel
Close
Sort by
Journal Articles

Mutations in DNMT3A , U2AF1 , and EZH2 Identify Intermediate-Risk Acute Myeloid Leukemia Patients with Poor Outcome after CR1

Caner Saygin, MD, Cassandra M. Hirsch, BS, Bartlomiej Przychodzen, M.S., Mikkael A. Sekeres, MD MS, Betty K. Hamilton, MD, Matt Kalaycio, MD, Hetty E. Carraway, MD MBA, Aaron T. Gerds, MDMS, Sudipto Mukherjee, MD PhD MPH, Aziz Nazha, MD, Ronald Sobecks, MD, Christopher Goebel, Donna M. Abounader, Jaroslaw P. Maciejewski, PhD MD FACP, Anjali S. Advani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2665.
https://doi.org/10.1182/blood.V130.Suppl_1.2665.2665
Published: 2017
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results

Anjali S. Advani, MD, Brenda W. Cooper, MD, Valeria Visconte, PhD, Paul Elson, PhD, E. Ricky Chan, PhD, Jennifer Carew, PhD, Sudipto Mukherjee, MD PhD MPH, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Paolo Caimi, MD, Benjamin Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Jaime Fensterl, Allison Unger, Cassie Zimmerman, Christopher Goebel, Nita Hoxha, Caitlin Siebenaller, Jenna Thomas, Mary Lynn Rush, RN, Samjhana Bogati, RN, Eric Parsons, RN, Rachael Diligente, RN, Donna Kane, RN, MSN, Alek Nielsen, BS, Cassandra M. Hirsch, BS, Simone Edelheit, Alexander Miron, PhD, John Pink, PhD, Jaroslaw P. Maciejewski, PhD MD FACP, Matt Kalaycio, MD, Marcos De Lima, MD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 150.
https://doi.org/10.1182/blood.V130.Suppl_1.150.150
Published: 2017
Journal Articles

Characteristics, Mutation Profiles and Outcomes of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease

Yazeed Sawalha, MD, Paul Elson, PhD, Yazan F. Madanat, MD, Nicole Droz, Apostolos Kontzias, Teodora Kuzmanovic, BA, Cassandra M. Hirsch, BS, Christopher Goebel, John Desamito, Benjamin Tomlinson, MD, Aziz Nazha, MD, Ronald Sobecks, MD, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD MPH, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Mikkael A. Sekeres, MD MS, Anjali S. Advani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2670.
https://doi.org/10.1182/blood.V130.Suppl_1.2670.2670
Published: 2017
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Anjali S. Advani, MD, Brenda Cooper, MD, Paul Elson, PhD, Sudipto Mukherjee, MD, PhD, M.P.H., Jaime Fensterl, Aaron T. Gerds, MD MS, Paolo F. Caimi, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Mary Lynn Rush, Samjhana Bogati, BSN, Eric Parsons, Donna Kane, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Barbara Bevier, Christopher Goebel, Cassie Zimmerman, MPH, Alek d Nielsen, B.S., Cassandra M. Hirsch, BSc, Jaroslaw P. Maciejewski, MD, PhD, FACP, Matt Kalaycio, MD, Marcos deLima, MD, James Jacobberger, Philip Woost, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2016) 128 (22): 4065.
https://doi.org/10.1182/blood.V128.22.4065.4065
Published: 2016